Bram Van Den Eeckhout
Gent, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Cross-species cellular mapping and humanization of Fcγ receptors to advance antibody modeling.
Journal: Science immunology
Published: January 30, 2026
CD4-directed nanoblades enable selective genome editing in CD4+ cells and HIV suppression in vitro and in vivo.
Journal: EMBO molecular medicine
Published: September 01, 2025
In-depth Analysis of the HIV Reservoir Confirms Effectiveness and Safety of Dolutegravir/Lamivudine in a Phase 4 Randomized Controlled Switch Trial (RUMBA).
Journal: The Journal of infectious diseases
Published: April 30, 2024
Rethinking IL-1 Antagonism in Respiratory Viral Infections: A Role for IL-1 Signaling in the Development of Antiviral T Cell Immunity.
Journal: International journal of molecular sciences
Published: September 24, 2023
A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state.
Journal: Molecular cancer
Published: August 13, 2023
Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication.
Journal: Journal for immunotherapy of cancer
Published: October 17, 2021
Targeting IFN activity to both B cells and plasmacytoid dendritic cells induces a robust tolerogenic response and protection against EAE.
Journal: Scientific reports
Published: July 09, 2021
Interleukin-1 as Innate Mediator of T Cell Immunity.
Journal: Frontiers in immunology
Published: October 27, 2020
Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant.
Journal: NPJ vaccines
Published: September 17, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026